Back to search
FDAFDA · Food and drugs·Recall number F-1208-2024

Longreen Corporation Xlim Express Coffee, 15 grams/sachet, 10 sachets/box

Published May 8, 2024 · Recall initiated: April 18, 2024

Summary

FDA records food Class II recall F-1208-2024, published May 8, 2024 and initiated April 18, 2024. Recalling firm: BF Suma Pharmaceuticals, Inc.; Status: Terminated; Reported quantity: 23,701 boxes; Lot: Batch No. C33619, Best By Date: 02 2026; Batch No. H33119, Best By Date: 07 2026; Batch No. H33219, Best By Date: 07 2026; Batch No. C40719, Best By Date: 02 2027; Batch No. C40819, Best By Date: 02 2027. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Undeclared allergens due to sub-ingredients, soy lecithin and coconut oil

What to do

Voluntary: Firm initiated · Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
BF Suma Pharmaceuticals, Inc.
Distributor
U.S. distribution to the following states: CA, TX. Foreign distribution to Canada and Guatemala.
Lot
Batch No. C33619, Best By Date: 02 2026; Batch No. H33119, Best By Date: 07 2026; Batch No. H33219, Best By Date: 07 2026; Batch No. C40719, Best By Date: 02 2027; Batch No. C40819, Best By Date: 02 2027
Risk classification
Class II
Area (FDA)
food
Country
United States

Related recalls

Questions about this recall

Was Longreen Corporation Xlim Express Coffee, 15 grams/sachet, 10 sachets/box recalled?

Yes. FDA published recall F-1208-2024 on May 8, 2024. Reported hazard: Undeclared allergens due to sub-ingredients, soy lecithin and coconut oil

What should I do if I have this product?

Voluntary: Firm initiated · Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit